FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Cornyn denies MAGA pressure forced support for talking filibuster on SAVE Act

Trump reveals top issues GOP should focus on to secure midterms victory: ‘I’ve never been more confident’

Trump calls SAVE America Act his ‘No. 1’ priority for House GOP

Obama Judge Gets Schooled by Appeals Court Following ‘Constitutionally Suspect’ Injunction Against DHS

The Hitchhiker’s Guide to the ‘talking filibuster’ and the SAVE Act

FBI subpoenas Arizona county voting records related to notorious 2020 audit

Zuckerberg Sued: Meta’s AI Glasses Accused of Recording Intimate Moments, Sending Footage to Foreign Contractors

40+ House Republicans rally behind Markwayne Mullin for DHS, call it a ‘critical moment’ for border security

Storage facility raided as feds investigate alleged ISIS-inspired NYC bomb throwers

Judge disqualifies Trump-appointed leadership in New Jersey US attorney’s office

US Not Happy with Israel Over Latest Iran Strikes: Report

Biden-appointed judge in the hot seat after DHS fires back at ‘false’ claims about ICE facility

Alexander brothers learn fate in federal sex trafficking trial

Trump Rejects Biden’s Executive Privilege Claim, Says It’s ‘Not in the Best Interests of the United States’

Police Bodycam Caught Chilling Statement from NYC Terror Suspect After He Was Taken Into Custody

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”